MoonLake Immunotherapeutics is a Swiss biotech developing SLK, an experimental Nanobody treatment for inflammatory skin and joint diseases. It last closed at $11.07 on Nov 20, up 0.36% on the day. The next earnings report for MLTX is expected around Mon, Feb 22, 2027. For the quarter ended Sep 2026, MLTX reported EPS of -$0.93. Over its last 8 reports the stock moved an average of 3.8% the session after earnings. Over the last 12 months MLTX insiders bought $0 of stock on the open market and sold $83.0M, according to SEC Form 4 filings.
AI Auto Pilots
Is MLTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MLTX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on MLTXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
MLTX · as of the Nov 20 close · updated each morning
Downtrend
The stock is 7% below its 20 day and 5% below its 50 day average. It is 46% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 44). The nearest support is the Pivot at $11.03, and the nearest resistance the Pivot R1 at $11.34.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 7.3%/day
Key levels
$23.2952 week high+110.4%
$16.16200 day average+46.0%
$14.47100 day average+30.7%
$12.95Swing high (Oct 29)+17.0%
$11.8720 day average+7.2%
$11.6150 day average+4.9%
$11.34Pivot R1+2.4%
$11.07Last close
$11.03Pivot−0.4%
$10.76Pivot S1−2.8%
$10.66Swing low (Nov 5)−3.7%
$9.4652 week low−14.5%
Indicators
RSI (14)
44.26
Middle of its range
Neutral
MACD
-0.11
Below its signal line
Bearish
Stochastic
9.2
Near the bottom of its range
Oversold
ADX (14)
19.7
No clear trend
Williams %R
-87.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-101.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−4.0%
Change over 10 sessions
Bearish
ATR (14)
$0.81
Typical daily range, 7.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 18.4%/day
Key levels
$23.2952 week high+110.4%
$16.16200 day average+46.0%
$14.47100 day average+30.7%
$12.95Swing high (Oct 29)+17.0%
$11.8720 day average+7.2%
$11.6150 day average+4.9%
$11.34Pivot R1+2.4%
$11.07Last close
$11.03Pivot−0.4%
$10.76Pivot S1−2.8%
$10.66Swing low (Nov 5)−3.7%
$9.4652 week low−14.5%
Indicators
RSI (14)
36.14
Weak, oversold below 30
Neutral
MACD
-1.93
Below its signal line
Bearish
Stochastic
27.0
Middle of its range
Neutral
ADX (14)
13.5
No clear trend
Williams %R
-78.2
Oversold below −80, overbought above −20
Neutral
CCI (20)
-67.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−11.5%
Change over 10 sessions
Bearish
ATR (14)
$2.04
Typical daily range, 18.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for MLTX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how MLTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow MLTX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for MLTXHow many large options trades hit MLTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in MLTX in the last 90 days.
From SEC Form 4 filings by MLTX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MLTX is in one of them and how their past MLTX trades turned out.
MoonLake Immunotherapeutics is a biotechnology company based in Zug, Switzerland, that is developing SLK, an experimental medicine for inflammatory skin and joint diseases. SLK is a Nanobody, a small antibody-like molecule, that blocks two related immune signals called IL-17A and IL-17F. The company is testing SLK in conditions such as hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis and palmoplantar pustulosis, for patients under the care of skin and joint specialists. It does not yet have an approved product.